Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katarzyna J Jerzak

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Prevalence of Breast Cancer Survivors Among Canadian WomenAmy A Kirkham, Katarzyna J Jerzak
Current Oncology (Toronto, Ont.)|August 28, 2024
An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and ManagementNathalie LeVasseur, Mita Manna, Katarzyna J Jerzak
Frontiers in Oncology|August 15, 2022
Karnofsky Performance Status (KPS) ≤60 Is Strongly Associated With Shorter Brain-Specific Progression-Free Survival Among Patients With Metastatic Breast Cancer With Brain MetastasesMark Freeman, Marguerite Ennis, Katarzyna J Jerzak
Journal of Diabetes|June 19, 2013
Willingness to take drugs to prevent serious chronic diseasesKatarzyna J Jerzak, Shelley Pallan, Hertzel C Gerstein
Gynecologic Oncology|January 9, 2019
Endocrine therapy in endometrial cancer: An old dog with new tricksKatarzyna J Jerzak, Linda Duska, Helen J MacKay
Oncotarget|November 8, 2019
Central nervous system-specific efficacy of CDK4/6 inhibitors in randomized controlled trials for metastatic breast cancerLong V Nguyen, Karlee Searle, Katarzyna J Jerzak
Expert Opinion on Pharmacotherapy|August 20, 2016
An update on adjuvant systemic therapy for elderly patients with early breast cancerKatarzyna J Jerzak, Danielle N Desautels, Kathleen I Pritchard
Annals of Palliative Medicine|September 11, 2019
Role of bone-modifying agents in advanced cancerDanielle N Desautels, Craig H Harlos, Katarzyna J Jerzak
The Oncologist|November 4, 2018
Takotsubo Cardiomyopathy During Anti-HER2 Therapy for Metastatic Breast CancerCaitlin Lees, Payam Yazdan-Ashoori, Katarzyna J Jerzak, et al.
Neuro-Oncology Advances|April 6, 2026
HR+/HER2- breast cancer brain metastases treated with definitive local therapy: a focus on endocrine sensitivity and incidence of leptomeningeal diseaseJie Wei Zhu, Arjun Sahgal, Veronika Moravan, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Prevalence of Breast Cancer Survivors Among Canadian WomenAmy A Kirkham, Katarzyna J Jerzak
Current Oncology (Toronto, Ont.)|August 28, 2024
An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and ManagementNathalie LeVasseur, Mita Manna, Katarzyna J Jerzak
Frontiers in Oncology|August 15, 2022
Karnofsky Performance Status (KPS) ≤60 Is Strongly Associated With Shorter Brain-Specific Progression-Free Survival Among Patients With Metastatic Breast Cancer With Brain MetastasesMark Freeman, Marguerite Ennis, Katarzyna J Jerzak
Journal of Diabetes|June 19, 2013
Willingness to take drugs to prevent serious chronic diseasesKatarzyna J Jerzak, Shelley Pallan, Hertzel C Gerstein
Gynecologic Oncology|January 9, 2019
Endocrine therapy in endometrial cancer: An old dog with new tricksKatarzyna J Jerzak, Linda Duska, Helen J MacKay
Oncotarget|November 8, 2019
Central nervous system-specific efficacy of CDK4/6 inhibitors in randomized controlled trials for metastatic breast cancerLong V Nguyen, Karlee Searle, Katarzyna J Jerzak
Expert Opinion on Pharmacotherapy|August 20, 2016
An update on adjuvant systemic therapy for elderly patients with early breast cancerKatarzyna J Jerzak, Danielle N Desautels, Kathleen I Pritchard
Annals of Palliative Medicine|September 11, 2019
Role of bone-modifying agents in advanced cancerDanielle N Desautels, Craig H Harlos, Katarzyna J Jerzak
The Oncologist|November 4, 2018
Takotsubo Cardiomyopathy During Anti-HER2 Therapy for Metastatic Breast CancerCaitlin Lees, Payam Yazdan-Ashoori, Katarzyna J Jerzak, et al.
Neuro-Oncology Advances|April 6, 2026
HR+/HER2- breast cancer brain metastases treated with definitive local therapy: a focus on endocrine sensitivity and incidence of leptomeningeal diseaseJie Wei Zhu, Arjun Sahgal, Veronika Moravan, et al.
Pageof 10